Lexicon Pharmaceuticals, Inc.
LXRX· Nasdaq
LXRXLexicon Pharmaceuticals, Inc.
Filed Aug 9, 2011 · 10-Q · 40 days after period end · 0001062822-11-000048
| Metric | Q2 2010 | Q2 2009 |
|---|---|---|
| Revenue | $555.00K | $1.23M |
| Net Income | -$26.64M | -$25.19M |
| EPS Diluted | -$0.08 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lexicon Pharmaceuticals, Inc. · CIK 1062822 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 9, 2011 · 40 d after period end
